Walking in Pregnancy and Prevention of Insomnia in Third Trimester Using Pedometers
NCT ID: NCT03735381
Last Updated: 2019-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
265 participants
INTERVENTIONAL
2019-06-02
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The SleepTrackTXT2 Randomized Trial With Air-medical Personnel
NCT02783027
A Cohort Study on Sleep Disorders During Pregnancy
NCT05765149
Objective Sleep Behavior in Relation to a Nigth Competition in Athletes.
NCT03773601
Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults-2
NCT03187340
Validation Study for an Unobtrusive Online Sleep Measurement System
NCT01633151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific Objectives: Comparison of the interventions group versus the control group; at the beginning, middle and end of the program of the following indicators: 1. Average steps/day; 2. Frequency of insomnia; 3. Hours of night sleep and quality of sleep; 4. Quality of life level.
Methodology: Randomized Control trial in parallel in healthy sedentary pregnant women belonging to the Virgen de las Nieves Hospital in Granada, Spain. At 12 weeks of gestation (GW) they will be invited to participate and randomly assigned to the intervention group I2 (pedometer, with goal of 11,000 steps / day), intervention group I1 (pedometer without goal) and control (without pedometer). Duration of the intervention: 13-32 GW. At 12, 19 and 31GW the average steps/day will be measured in groups I2 and I1. In weeks 13, 20 and 32GW, the following variables will be collected: the Athens Insomnia Scale, the Sleep Quality Index (Pittsburgh), adherence to the Mediterranean Diet (Predimed), physical activity (short IPAQ), quality of life (PSI), the consumption of toxic substances (caffeine, illegal drugs, alcohol and tobacco), the anthropometric variables of pregnant woman.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention 1: pedometer
Minimum intervention:
1. Use of pedometer watch from 12 to 32 GW
2. Recommendations of physical activity
Pedometer watch 'Xiomi mi band2'
1. They receive information on the use of the pedometer.
2. Carry the pedometer (Xiaomi Mi Band 2 ™) from 12 to 32GW.
3. Prescription of benefits of walking in pregnancy:
* Receive information about the goal of steps / day to be reached: 10,000-11,000 steps / day (Only the intervention 2 group).
* Receive information on the adequacy of walking with moderate intensity.
4. They will receive messages on the mobile phone remembering the goal to achieve and a notification that the researching staff will proceed to collect the average count of steps / day of the week prior to 20 and 32 gestation weeks (only for the intervention 2 group).
Intervention 2: pedometer+goal+reminds
Maximum intervention:
1. Use of pedometer from 12 to 32 GW
2. Recommendations of physical activity
3. Information about get a goal of 11000 steps/day
4. Reminds the goal every two weeks.
Pedometer watch 'Xiomi mi band2'
1. They receive information on the use of the pedometer.
2. Carry the pedometer (Xiaomi Mi Band 2 ™) from 12 to 32GW.
3. Prescription of benefits of walking in pregnancy:
* Receive information about the goal of steps / day to be reached: 10,000-11,000 steps / day (Only the intervention 2 group).
* Receive information on the adequacy of walking with moderate intensity.
4. They will receive messages on the mobile phone remembering the goal to achieve and a notification that the researching staff will proceed to collect the average count of steps / day of the week prior to 20 and 32 gestation weeks (only for the intervention 2 group).
Control: without pedometer
Women receive some recommendations of physical activity during pregnancy. They do not use the pedometer during pregnancy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pedometer watch 'Xiomi mi band2'
1. They receive information on the use of the pedometer.
2. Carry the pedometer (Xiaomi Mi Band 2 ™) from 12 to 32GW.
3. Prescription of benefits of walking in pregnancy:
* Receive information about the goal of steps / day to be reached: 10,000-11,000 steps / day (Only the intervention 2 group).
* Receive information on the adequacy of walking with moderate intensity.
4. They will receive messages on the mobile phone remembering the goal to achieve and a notification that the researching staff will proceed to collect the average count of steps / day of the week prior to 20 and 32 gestation weeks (only for the intervention 2 group).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sedentary women (\<5 days/week of moderate-vigorous physical activity at least \>30 min.; equivalent to \<7.000 steps/day).
* With mobile phone and e-mail
* Without intellectual deficits or difficulty to understand the language.
Exclusion Criteria
* Women with relative or absolute repose.
* Active women (\>5 days/week of moderate-vigorous physical activity at least \>30 min.; equivalent to \>7.000 steps/day).
* Insomnia at beginning of pregnancy or having drugs for sleep problems.
18 Years
49 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Granada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carmen Amezcua Prieto
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carmen Amezcua Prieto
Role: PRINCIPAL_INVESTIGATOR
Universidad de Granada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Virgen de las Nieves
Granada, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Benito-Villena R, Cano-Ibanez N, Roman-Galvez RM, Martin-Pelaez S, Khan KS, Martinez-Galiano JM, Mozas-Moreno J, Amezcua-Prieto C. Gestational weight gain and daily life impact of pregnancy symptoms in healthy women: A multivariable analysis. Eur J Obstet Gynecol Reprod Biol. 2024 Dec;303:85-90. doi: 10.1016/j.ejogrb.2024.10.023. Epub 2024 Oct 16.
Amezcua-Prieto C, Naveiro-Fuentes M, Arco-Jimenez N, Olmedo-Requena R, Barrios-Rodriguez R, Vico-Zuniga I, Manzanares Galan S, Mozas-Moreno J, Jimenez-Moleon JJ, Gallo-Vallejo JL. Walking in pregnancy and prevention of insomnia in third trimester using pedometers: study protocol of Walking_Preg project (WPP). A randomized controlled trial. BMC Pregnancy Childbirth. 2020 Sep 10;20(1):521. doi: 10.1186/s12884-020-03225-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI-0350-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.